Genmab — Maj 2020

[AaBforever]

Stay away...:-D

[E_L]

a bit disappointing though to be honest, if you open at 2140...

[E_L]

yes sry lol

[Helge_LarsenPI-redaktør]

Man kan jo undre sig over hvordan man styrer salget af en sådan stor portion aktier på plads, så kursen lander præces som udgangspunktet før auktionen.

[AaBforever]

Måske hvis man virklig´ har kæmpe store økonomiske muskler.

[E_L]

Selinexor, daratumumab,https://twitter.com/MM_Hub/status/1266382542904721408

[Helge_LarsenPI-redaktør]

Impressive.

[E_L]

amivantimab etc https://twitter.com/Jbauml/status/1266419491774349313

[E_L]

and the poster https://twitter.com/ivybelkins/status/1266419775347007489

[Helge_LarsenPI-redaktør]

Thank you E L for your dedication. We are so grateful for your work every day of the year here at PI.

[E_L]

you make me blush now lol. we all try to make ourselves a little bit usefull here!

[E_L]

If I had known that I would be in this stock this long, and had i been really dedicated, i could have learned Danish in that time

[transalp]

good luck with the Danish, you still have time to learn.. go weekend til alle, her oppe i de høje kurslag..

[bibob]

And you will be in this Stock for 10-20 more years, so you can start now . PI will be your censor.

[E_L]

[bibob]

Dr. Bahlis on opdated data of the MAIA trial in Multiple Myeloma. https://www.onclive.com/onclive-tv/dr-bahlis-on-updated-data-from-the-maia-trial-in-multiple-myeloma

[bibob]

Sc Dara submitted for japanese approval in Myeloma. https://www.onclive.com/web-exclusives/subcutaneous-daratumumab-submitted-for-japanese-approval-in-myeloma

[Helge_LarsenPI-redaktør]

Tusinde tak Bibob.

[Mcjean]

20.50 Agree Helge he absolute world class getting information out to hes amateur colleaques:-)

[Bulder]

Vedr epcoritamab: De 48 mg er ikke "chosen dose" men anbefalet fase 2 dosis, som nu skal undersøges nærmere i fase 1/2 studiets expansionsfase. Den dosis kan godt blive ændret, når de går i gang med det egentlige fase 2 studie.